Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02802592 · ClinicalTrials.gov registry record · Phase 1
EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)
A Phase 1 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT02802592: Clinical Trial Phase 1 study, sponsored by Johns Hopkins University.
NCT02802592 is a Phase 1 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02802592, a Phase 1 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)
Interventions
- DRUG Normal Saline
- DRUG Epogen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2015-05 |
| Est. Completion | 2017-02-27 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02802592
The ClinicalTrials.gov registry entry for NCT02802592 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal Saline is the first listed.
NCT02802592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02802592 about?
NCT02802592 is a clinical study titled "EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)". EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)
What is the current status of trial NCT02802592?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2015-05. Estimated completion is 2017-02-27.
What interventions are being tested in trial NCT02802592?
The interventions under investigation include: Normal Saline (DRUG), Epogen (DRUG).
Who is sponsoring clinical trial NCT02802592?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.